Novo Nordisk stock before the bell after a 1.26 percent drop

At the close on September 10, 2026, Novo Nordisk stock finished at EUR 38.02 on Frankfurt, down 1.26 percent. The shares traded between EUR 38.01 and EUR 38.78, while the Nasdaq 100 fell 0.65 percent on the same session.

Novo Nordisk stock closed at EUR 38.02 on Frankfurt on September 10, 2026, down 1.26 percent. The move came with volume of 15,761 shares and a day range of EUR 38.01 to EUR 38.78.

September 10, 2026 close

Novo Nordisk A/S (ISIN DK0062498333) also finished above its 52-week low of EUR 30.29 and below its 52-week high of EUR 54.86. The stock's session range stayed within that broader band, and the close sat slightly above the session low.

As Reuters reported on September 10, 2026, Novo Nordisk said Wegovy was approved in China for treatment of MASH. Reuters also said the drug was the first GLP-1 RA class treatment approved there for that use.

Today before the open

Novo Nordisk's Capital Markets Day 2026 page remains in view ahead of the session, and the company is due to update investors later this month. The page points to the company's investor materials for Capital Markets Day 2026.